Based on the primary findings of this study, we have also preliminarily explored the potential of MAGI3 as a prognostic biomarker in other types of renal cancer, such as kidney renal papillary cell carcinoma and chromophobe renal cell carcinoma. Here, MAGI3 is linked to chromophobe renal cell carcinoma.